* * * * * 　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　｜ CONTACT US ｜ SITE MAP ｜ 日本語 ｜

JOURNAL CLUB

Here is a list of papers introduced in the recent seminar of our laboratory.
The lab undergraduate/graduate students choose from Alzheimer's disease-related and recently published papers with high impact.

・Apr. 1, 2021 - Mar. 31, 2022　□
・Apr. 1, 2020 - Mar. 31, 2021　□
・Apr. 1, 2019 - Mar. 31, 2020　□
・Apr. 1, 2018 - Mar. 31, 2019　□
・Apr. 1, 2017 - Mar. 31, 2018　□
・Apr. 1, 2016 - Mar. 31, 2017　□
・Apr. 1, 2015 - Mar. 31, 2016　□
・Apr. 1, 2014 - Mar. 31, 2015　□
・Apr. 1, 2013 - Mar. 31, 2014　□
・Apr. 1, 2012 - Mar. 31, 2013　□

*, corresponding author; ^#, equal contribution

#8　(2022/4/28; by MN)

Ogata K, Kadono F, Hirai Y, Inoue K, Takada M, Karube F, Fujiyama F.
Conservation of the direct and indirect pathway dichotomy in mouse caudal striatum with uneven distribution of dopamine receptor D1- and D2-expressing neurons.
Front Neuroanat 2022;16:809446
PMID: 35185482

#7　(2022/4/28; by MM)

Bhattacharjee S, Zhao Y, Dua P, Rogaev EI, Lukiw WJ.
microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular Degeneration.
PLoS One 2016; 11(3):e0150211
PMID: 26949937

#6　(2022/4/22; by GS)

Ledo JH, Liebmann T, Zhang R, Chang JC, Azevedo EP, Wong E, Silva HM, Troyanskaya OG, Bustos V, Greengard P.
Presenilin 1 phosphorylation regulates amyloid-β degradation by microglia.
Mol Psychiatry 2022;26:5620–5635
PMID: 32792660

#5　(2022/4/22; by RI)

Sato K, Watamura N, Fujioka R, Mihira N, Sekiguchi M, Nagata K, Ohshima T, Saito T, Saido TC, Sasaguri H.
A third-generation mouse model of Alzheimer's disease shows early and increased cored plaque pathology composed of wild-type human amyloid β peptide.
J Biol Chem 2021; 297(3): 101004
PMID: 34329683

#4　(2022/4/15; by AI)

Kenkhuis B, Somarakis A, Kleindouwel LRT, van Roon-Mom WMC, Höllt T, van der Weerd L.
Co-expression patterns of microglia markers Iba1, TMEM119 and P2RY12 in Alzheimer's disease.
Neurobiol Dis 2022;167:105684
PMID: 35247551

#3　(2022/4/15; by KN)

Lloyd JT, Yee AG, Kalligappa PK, Jabed A, Cheung PY, Todd KL, Karunasinghe RN, Vlajkovic SM, Freestone PS, Lipski J.
Dopamine Dysregulation and Altered Responses to Drugs Affecting Dopaminergic Transmission in a New Dopamine Transporter Knockout (DAT-KO) Rat Model.
Neuroscience 2022; S0306-4522(22)00135-X
PMID: 35331847

#2　(2022/4/8; by MF)

Nelde A, Flötotto L, Jürgens L, Szymik L, Hubert E, Bauer J, Schliemann C, Kessler T, Lenz G, Rammensee HG, Walz JS, Wethmar K.
Upstream open reading frames regulate translation of cancer-associated transcripts and encode HLA-presented immunogenic tumor antigens.
Cell Mol Life Sci 2022;79(3):171
PMID: 34694469

#1　(2022/4/8; by AH)

Reinwald JR, Gass N, Mallien AS, Sartorius A, Becker R, Sack M, Falfan-Melgoza C, Clemm von Hohenberg C, Leo D, Pfeiffer N, Middelman A, Meyer-Lindenberg A, Homberg JR, Weber-Fahr W, Gass P.
Dopamine transporter silencing in the rat: systems-level alterations in striato-cerebellar and prefrontal-midbrain circuits.
Mol Psychiatry 2022, in press.
PMID: 35239002